Sprockhövel, Germany

Mathias Berwe

USPTO Granted Patents = 10 


 

Average Co-Inventor Count = 5.1

ph-index = 4

Forward Citations = 52(Granted Patents)


Location History:

  • Sprockhövel, DE (2001 - 2012)
  • Sprockhovel, DE (2017 - 2019)
  • Sprockhoevel, DE (2013 - 2022)

Company Filing History:


Years Active: 2001-2022

Loading Chart...
Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents

Title: Innovator Mathias Berwe: Pioneering Advances in Pharmaceutical Chemistry

Introduction

Mathias Berwe, based in Sprockhövel, Germany, is an accomplished inventor with a remarkable portfolio of 10 patents. His work primarily revolves around innovations in pharmaceutical chemistry, contributing significantly to the development of drug formulations and synthesis methods.

Latest Patents

Among his latest inventions, two patents stand out for their innovative methodologies. The first patent details a "Method for the hydrolysis of quinolonecarboxylic esters," which outlines a process for hydrolyzing quinolonecarboxylic esters to produce quinolonecarboxylic acids. This method employs a specific reaction with a mixture of acetic acid, sulfuric acid, and water, proving particularly effective for synthesizing intermediates needed in the production of pradofloxacin.

The second patent involves "Amorphous Letermovir and solid pharmaceutical formulations thereof for oral administration." This invention presents a method for isolating amorphous Letermovir from organic solutions and describes a formulation that is suitable for immediate release. This immediate release formulation is designed to assist in the treatment and prevention of diseases associated with the Herpesviridae family, particularly targeting cytomegalovirus (CMV) infections.

Career Highlights

Mathias Berwe's career has been marked by significant contributions to the pharmaceutical industry through his role at prominent companies such as Aicuris GmbH & Co. KG and Bayer Healthcare Aktiengesellschaft. His innovative approaches in these organizations have laid the groundwork for numerous advancements in medicinal chemistry.

Collaborations

Throughout his career, Mathias has collaborated with esteemed colleagues like Oliver Kuhn and Hans-Christian Militzer. These partnerships have fostered an environment of shared knowledge and innovation, leading to the successful development of groundbreaking pharmaceutical products.

Conclusion

With a rich background in pharmaceutical chemistry and a notable collection of patents, Mathias Berwe continues to be a driving force in the field of innovation. His methodologies not only advance scientific understanding but also provide invaluable resources for the treatment of serious health conditions, emphasizing the importance of his work in the medical community.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…